Supporting Moms and Babies Affected by Substance Use: A New Approach to Care

In the past, mothers whose babies were exposed to substances like opioids during pregnancy often faced judgment and limited support. Oklahoma Children’s Hospital OU Health is leading a compassionate, research-backed shift in care that surrounds both mom and baby with the help they need from birth through early childhood.

Thanks to new funding from the American Academy of Pediatrics, Oklahoma Children’s Hospital is refining how it supports families when babies are born with neonatal abstinence syndrome (NAS), a condition where newborns experience withdrawal symptoms due to substance exposure in the womb.

This initiative is powered by the joint clinical, research, and educational missions of OU Health and The University of Oklahoma, where care, science, and training come together to create lasting impact.

Oklahoma Children's Hospital neonatologist Patricia K. Williams, M.D. and developmental and behavioral pediatrician Susan Redwine M.D., both associate professors of pediatrics at OU College of Medicine, are co-leaders of the project.

What This Means for Families:

• Gentler hospital care — soothing techniques, sleep support, and feeding help, with medication only when needed
• Stronger discharge planning — a full team ensures families are ready for home care
• Ongoing support at home — safe sleep tools, breastfeeding guidance, and community resources

This approach is about compassion, continuity and community, giving families the tools and support they need to thrive, not just survive.

Learn more about reducing the stigma of NAS and supportive care for mother’s and their babies.

OU Receives Funding to Enhance Care for Babies Exposed to Substances in Womb